Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer

By Hoff Paulo   Saad Everardo   Pazdur Richard   Wolff Robert   Lassere Yvonne   Bogaard Karla   Abbruzzese James  

Investigational New Drugs, Vol. 22, Iss. 3, 2004-08 ,pp. : 307-313

Springer Publishing Company

Access to resources Recommend Favorite

Modified-Irinotecan/Fluorouracil/Levoleucovorin Therapy as Ambulatory Treatment for Metastatic Colorectal Cancer: Results of Phase I and II Studies

By Yuuki Satoshi  

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 243-249

Adis International

Access to resources Recommend Favorite

Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer

By Yamada Yasuhide  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1690-1696

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

By Kim Sun   Hong Yong   Kim Byung   Park Ji   Choi Hyo   Jeong Seung-Yong   Kim Dae   Hong Chang   Sohn Dae   Jung Kyung  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite

Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

By Sánchez Rosa   Esteban Emilio   Palacio Isabel   Fernández Yolanda   Muñiz Isabel   Vieitez Jose M.   Fra Joaquin   Blay Pilar   Villanueva Noemí   Uña Esther   Mareque Beatriz   Estrada Enrique   Buesa Jose M.   Lacave Angel J.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 459-463

Springer Publishing Company

Access to resources Recommend Favorite